Dr. Linda Wastila, Professor at the University of Maryland Baltimore School of Pharmacy, gave her testimony during a three-hour panel discussion hosted by U.S. Senator Ron Johnson on 3 November in Washington D.C. The expert panel included doctors and medical researchers who treat Covid injection injuries and they were joined by patients who have experienced adverse events to Covid injections.
Prof. Wastila has conducted policy and epidemiological research focusing on intended and unintended outcomes of clinical and policy interventions involving medications and their safety over the past 30 years. She and several colleagues, including Dr. Peter Doshi, formed a group – Coalition Advocating for Adequately Licensed Medicines (“CAALM”) – and in June they submitted a petition to the U.S. Food and Drug Administration (“FDA”) regarding the experimental Covid injections.
Their petition made several requests including: the FDA require manufacturers to submit data from completed Phase III trials; the FDA require a more thorough assessment of spike proteins produced in-situ by the body following vaccination and demand manufacturers complete proper biodistribution studies; and asked for data demonstrating a thorough investigation of all serious adverse events reported to pharmacovigilance systems.
Prof. Wastila gave an opening statement at the start of the expert panel discussion which you can watch HERE.
In her second statement Prof. Wastila spoke about the science of vaccine safety. “Unless you are dealing with an inert substance every product has side-effects and the Covid-19 vaccines are no exception,” she said.
“The timeline for noticing, researching and establishing harm is slow. Take myocarditis. It took four months into Israel’s vaccination campaign to recognise this side effect – that’s despite the fact that myocarditis generally strikes within days of dosing, particularly the second dose. So, people were experiencing these ‘side-effects’ for months before officials acknowledged the vaccines as cause.”
